Status:
COMPLETED
13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)
Lead Sponsor:
Meridian Bioscience, Inc.
Collaborating Sponsors:
Rabin Medical Center
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Approximately 200 patients with suspected H.pylori will be tested with a 13C-Urea Breath Test (UBT) to ascertain H.pylori positive. 100 H.Pylori positive patients will tested before and after prescrib...
Detailed Description
Adult subjects with suspected H pylori infection will be recruited and will undergo a 13C -Urea breath test (including citrica) with the BreathID test device. Those were found positive will undergo se...
Eligibility Criteria
Inclusion
- Adults with H.pylori infection.
Exclusion
- Pregnancy,
- Nursing,
- Antibiotic, bismuth or PPI treatment 2 weeks prior to trial,
- Known sensitivity to Urea or citrica.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT00825630
Start Date
November 1 2008
End Date
November 1 2009
Last Update
December 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel, 49100